Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Vaccine
25.04.2022
Viruses & Microorganisms, Disease, Drugs & Diagnostics, Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
FDA approves third-generation hepatitis B vaccine based on Weizmann research
26.04.2020
Dr. Ron Diskin of the Weizmann Institute's Structural Biology Department is concentrating his efforts on a two-pronged research...
07.10.2019
Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease
12.09.2010
Bio-Hep-B, a vaccine for hepatitis B based on Prof. Shaul's research, is produced by Biotechnology General and marketed in Israel
01.05.2009
From student to Institute Vice President
01.10.2006
Institute scientists show precisely how a diabetes vaccine works
30.08.2006
Biochemistry, Viruses & Microorganisms, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics
Weizmann Institute scientists render a disease-causing pathogen harmless
...
19.06.2006
A team of researchers led by Prof. Irun Cohen of the Weizmann Institute of Science Immunology Department has revealed the...
01.10.2004
The uncannily devious flu virus, it turns out, has an Achilles’ heel
